- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/37 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Patent holdings for IPC class C07C 311/37
Total number of patents in this class: 79
10-year publication summary
9
|
8
|
9
|
6
|
3
|
5
|
4
|
2
|
4
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Centre hospitalier Regional et universitaire de Lille (chru) | 34 |
4 |
Fresenius Kabi Oncology Limited | 66 |
3 |
Janssen Sciences Ireland UC | 183 |
3 |
Research Triangle Institute | 406 |
3 |
University of Utah Research Foundation | 1821 |
3 |
Novartis AG | 10725 |
2 |
F. Hoffmann-La Roche AG | 7947 |
2 |
The Regents of the University of California | 20087 |
2 |
Merck Sharp & Dohme Corp. | 2191 |
2 |
Duke University | 3087 |
2 |
Purdue Research Foundation | 3670 |
2 |
Cornell University | 3330 |
2 |
Ithaca College | 19 |
2 |
Pharmaxis Ltd | 38 |
2 |
Proximagen Limited | 41 |
2 |
Universite de Lille 2 droit et Sante | 206 |
2 |
Merck Patent GmbH | 5768 |
1 |
Massachusetts Institute of Technology | 10110 |
1 |
Board of Regents, The University of Texas System | 5860 |
1 |
President and Fellows of Harvard College | 5998 |
1 |
Other owners | 37 |